Impaired acute‐phase humoral immunity is the major factor predicting unfavorable outcomes in multiple myeloma patients with SARS ‐ CoV ‐2 Omicron variants outbreak infection

Ähnliche Einträge

• Internal drivers of the global pandemic of the Omicron variants of SARS‐CoV‐2
  von: Yilin Niu, et al.
  Veröffentlicht: (2024)
• A mini review of reinfection with the SARS‐CoV‐2 Omicron variant
  von: Hongwei Shen, et al.
  Veröffentlicht: (2024)
• Skin manifestations of SARS‐CoV‐2 Omicron variant: Clinical, pathological, and immunological insights
  von: Yuling Zhang, et al.
  Veröffentlicht: (2024)
• Omicron BA.4/5 neutralization and cell‐mediated immune responses in relation to baseline immune status and breakthrough infection among PLWH: A follow‐up cohort study
  von: Haoting Zhan, et al.
  Veröffentlicht: (2024)
• Evidence for fomite transmission of SARS‐CoV‐2 Omicron variant in a mouse model
  von: Sidi Yang, et al.
  Veröffentlicht: (2025)